Those holding Canopy Growth Corporation (TSE:WEED) shares would be relieved that the share price has rebounded 40% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Still, the 30-day jump doesn’t change the fact that longer term shareholders have seen their stock decimated by the 85% share price drop in the last twelve months.
Since its price has surged higher, you could be forgiven for thinking Canopy Growth is a stock not worth researching with a price-to-sales ratios (or “P/S”) of 1.3x, considering almost half the companies in Canada’s Pharmaceuticals industry have P/S ratios below 0.7x. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the elevated P/S.
Our free stock report includes 3 warning signs investors should be aware of before investing in Canopy Growth. Read for free now.
